The U.S. Food and Drug Administration (FDA) is warning consumers, patients and healthcare providers about the potential risk for serious complications from radiofrequency (RF) microneedling procedures.
An already-available genetic test might spare some melanoma patients from a surgical procedure to see whether their cancer has spread to their lymph nodes.
